Health Trials

Meropenem

3

Review clinical trials related to Meropenem. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).

Participants needed: 300
Trial details
Age: Up to 15Biological sex: AllType: InterventionalSponsor: University Hospital, GhentUpdated: Jan 16, 2026Locations: 3
Eligibility criteria

patients admitted to the pediatric intensive care unit or cardiac intensive care... [+4]

no catheter in place for blood sampling [+2]

Read more
Status: Recruiting

Antibiotic Dosing in Pediatric Intensive Care

Pharmacokinetics of antibiotics in critically ill neonates, infants and children

Participants needed: 640
Trial details
Age: 1-16Biological sex: AllType: ObservationalSponsor: University Hospital, GhentUpdated: Jan 16, 2026Locations: 1Duration: 3 Days
Eligibility criteria

patients admitted to the pediatric intensive care unit [+3]

no catheter in place for blood sampling [+3]

Read more
Status: Not yet recruiting

Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

The overall objective of this study is to investigate the impact of early model-informed precision dosing (MIPD) on target attainment of three beta-lactam antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem) in critically ill children. This evaluation includes a comparison with the more standard approach on clinical and patient-oriented measures.

Participants needed: 58
Trial details
Phase: Phase 4Age: 0-18Biological sex: AllType: InterventionalSponsor: University Hospital, GhentUpdated: Apr 16, 2025Locations: 1
Eligibility criteria

Subject aged between 0 - 17 years 10 months. [+7]

Subject with serum creatinine level ≥ 2 mg/L at inclusion. [+6]

Read more